-+ 0.00%
-+ 0.00%
-+ 0.00%

Immunovia survey finds 91% of high-risk patients comfortable using blood test for early pancreatic cancer detection

PUBT·08/13/2026 05:07:49
Listen to the news
Immunovia survey finds 91% of high-risk patients comfortable using blood test for early pancreatic cancer detection
  • Immunovia released results from the ADHERE survey of 392 high-risk individuals, assessing acceptance of blood-based pancreatic cancer screening.
  • Results have already been presented, showing broad comfort with using a blood test for earlier detection, often alongside imaging.
  • Findings point to a gap between willingness to enroll in surveillance and actual participation, supporting demand for easier screening options.
  • Management framed the data as strengthening the commercial case for PancreaSure as a complement to existing surveillance pathways.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovia AB published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.